Investor relations

press releases

03/18/2021

PainReform Provides Year-End Business Update and Reports Progress Towards Commencing Phase 3 Trial of PRF-110 for Non-Opiate Post-Operative Pain Relief

03/11/2021

PainReform to Participate at M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference

03/08/2021

PainReform Announces $6.0 Million Private Placement

01/07/2021

PainReform to Present at the H.C. Wainwright Bioconnect 2021 Conference

01/06/2021

PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110

01/04/2021

PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations